Pankaj Jain of SW Capital told CNBC-TV18, "JB Chemicals in last two years has done pretty well. It has appreciated quite a well. To best of my knowledge JB Chemical is not one of those stock which is seriously affected by the activism of USFDA. Rather they have been exploring new geographies. The topline has been increasing steadily.""They have very solid cash in hand, cash on books. Recently they have announced this special dividend or interim dividend. Even dividend yield is pretty strong. Company expects some bit of approvals, large number of approvals in next one year or so." "All in all I think these are all ingredients of a good quality stock which is doing well, decent quality of management. So, if you have a one to two year kind of horizon, I think you should make serious money out of this stock from current valuations, current sort of rate. So, stay with the stock, give it a longer time horizon and you will do pretty well," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
